Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Regulatory Filings 2021

Mar 22, 2021

33003_rns_2021-03-22_4b4b8f36-c345-467f-a985-f87ad36c80d4.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm CORRESP

March 22, 2021

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Attention: Margaret Schwartz

Re: Solid Biosciences Inc.

Registration Statement on Form S-3

File No. 333-254310

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Solid Biosciences Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-254310), so that it may become effective at 4:30 p.m., Eastern time, on March 24, 2021, or as soon as practicable thereafter.

Very truly yours,

By:
Ilan Ganot
Chief Executive Officer